BG
NVAX icon

BlackRock Group’s Novavax NVAX Stock Holding History

BlackRock Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$217K Buy
8,616
+549
+7% +$16K ﹤0.01% 2635
2016
Q3 		$335K Buy
8,067
+52
+0.6% +$6.71K ﹤0.01% 2449
2016
Q2 		$1.17M Sell
8,015
-79
-1% -$9.05K ﹤0.01% 1894
2016
Q1 		$836K Sell
8,094
-85
-1% -$9.12K ﹤0.01% 2022
2015
Q4 		$1.37M Sell
8,179
-105
-1% -$16.2K ﹤0.01% 1699
2015
Q3 		$1.17M Buy
8,284
+3,383
+69% +$759K ﹤0.01% 1789
2015
Q2 		$1.09M Buy
4,901
+2,091
+74% +$368K ﹤0.01% 1914
2015
Q1 		$464K Sell
2,810
-96
-3% -$15.6K ﹤0.01% 2232
2014
Q4 		$345K Buy
2,906
+130
+5% +$13.6K ﹤0.01% 2354
2014
Q3 		$231K Sell
2,776
-38
-1% -$3.43K ﹤0.01% 2405
2014
Q2 		$260K Sell
2,814
-2,341
-45% -$206K ﹤0.01% 2388
2014
Q1 		$467K Buy
5,155
+795
+18% +$88.8K ﹤0.01% 2259
2013
Q4 		$447K Buy
4,360
+757
+21% +$53.5K ﹤0.01% 2250
2013
Q3 		$227K Buy
3,603
+1,935
+116% +$109K ﹤0.01% 2453
2013
Q2 		$68K Buy
+1,668
New +$72.3K ﹤0.01% 2409

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Group's NVAX Position: Q4 2016 in Review

BlackRock Group increased its Novavax (NVAX) stake by 6.8% in Q4 2016, buying an estimated $16K and bringing the position to 8,616 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

BlackRock Group first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.37M in Q4 2015. 142 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

  • BlackRock Group held 8,616 shares of Novavax worth $217K as of Q4 2016.
  • BlackRock Group bought 549 Novavax shares in Q4 2016, an estimated $16K.
  • Novavax made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2635 holding.
  • BlackRock Group first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Novavax position peaked at $1.37M in Q4 2015.
  • 142 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.